Loading…

Maternal serum levels of interferon‐γ and interleukin‐2 soluble receptor‐α predict the outcome of early IVF pregnancies

BACKGROUND: Elevated maternal serum levels of interleukin‐2 soluble receptor‐α (IL‐2 sRα), tumour necrosis factor‐α (TNF‐α) and interferon‐γ (IFN‐γ) have been associated with pregnancy loss. The aim of our study was to evaluate the predictive value of these cytokines in the outcome of early IVF preg...

Full description

Saved in:
Bibliographic Details
Published in:Human reproduction (Oxford) 2004-06, Vol.19 (6), p.1357-1363
Main Authors: Fasouliotis, S.J., Spandorfer, S.D., Witkin, S.S., Schattman, G., Liu, H.C., Roberts, J.E., Rosenwaks, Z.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND: Elevated maternal serum levels of interleukin‐2 soluble receptor‐α (IL‐2 sRα), tumour necrosis factor‐α (TNF‐α) and interferon‐γ (IFN‐γ) have been associated with pregnancy loss. The aim of our study was to evaluate the predictive value of these cytokines in the outcome of early IVF pregnancies. METHODS: One hundred and fifty‐nine consecutive IVF patients who were subsequently diagnosed to have a biochemical pregnancy (n = 23), a first‐trimester miscarriage (n = 19) or a normal term delivery (n = 117) were included in this study. Serum was collected from the initial pregnancy test, 11 days after a day 3 embryo transfer, and all samples were analysed for IL‐2 sRα, TNF‐α and IFN‐γ by commercially available enzyme‐linked immunosorbent assay (ELISA) kits. RESULTS: IL‐2 sRα levels were significantly higher in patients with an early pregnancy loss compared with patients with a normal term delivery (849.5 ± 69.6 versus 693.5 ± 31.2 pg/ml, P = 0.02), and a cut‐off point of IL‐2 sRα >1000 pg/ml predicted a poor pregnancy outcome (44.4 versus 22.7% pregnancy loss, IL‐2 sRα ≥1000 versus IL‐2 sRα
ISSN:0268-1161
1460-2350
DOI:10.1093/humrep/deh169